Champions Oncology, Inc.CSBRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank87
3Y CAGR+3.6%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+3.6%/yr
vs +20.7%/yr prior
Acceleration
-17.2pp
Decelerating
Percentile
P87
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$4.39M-40.5%
2025$7.39M+220.4%
2024$-6.14M-255.2%
2023$3.96M-39.1%
2022$6.50M+486.5%
2021$-1.68M-157.9%
2020$2.90M+56.0%
2019$1.86M+251.9%
2018$-1.23M+56.8%
2017$-2.84M-